NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS
Monday, July 20, 2026 1 min read
Key Takeaway: NeoGenomics has announced a settlement regarding its voluntary disclosure to the Office of Inspector General for Health and Human Services (OIG-HHS). This settlement reflects the company's efforts to address compliance matters proactively. The announcement highlights NeoGenomics' commitment to maintaining regulatory standards.
Price reaction · baseline $14.24 (2026-07-20 close) · hit after-hours · clean, no other NEO news in the window
day 0 close · peak
+1.5%
Market Sentiment Analysis
POSITIVE FACTORS
Settlement indicates a resolution to compliance issues.
Voluntary disclosure shows proactive approach by NeoGenomics.
Full Press Release Details
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS
Frequently Asked Questions
What did NeoGenomics announce recently?
NeoGenomics announced a settlement related to its voluntary disclosure to OIG-HHS.
What does the settlement indicate?
The settlement indicates a resolution to compliance issues faced by NeoGenomics.
What is OIG-HHS?
OIG-HHS stands for the Office of Inspector General for Health and Human Services.
Why is the settlement significant?
The settlement reflects NeoGenomics' proactive approach to addressing compliance matters.